Literature DB >> 32170926

Macrophage lineages in heart valve development and disease.

Andrew J Kim1, Na Xu1, Katherine E Yutzey1.   

Abstract

Heterogeneous macrophage lineages are present in the aortic and mitral valves of the heart during development and disease. These populations include resident macrophages of embryonic origins and recruited monocyte-derived macrophages prevalent in disease. Soon after birth, macrophages from haematopoietic lineages are recruited to the heart valves, and bone marrow transplantation studies in mice demonstrate that haematopoietic-derived macrophages continue to invest adult valves. During myxomatous heart valve disease, monocyte-derived macrophages are recruited to the heart valves and they contribute to valve degeneration in a mouse model of Marfan syndrome. Here, we review recent studies of macrophage lineages in heart valve development and disease with discussion of clinical significance and therapeutic applications. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Heart valve; Macrophage; Myxomatous valve disease; Valve development

Mesh:

Substances:

Year:  2021        PMID: 32170926      PMCID: PMC8453806          DOI: 10.1093/cvr/cvaa062

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  95 in total

1.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 2.  Tissue-Resident Macrophage Ontogeny and Homeostasis.

Authors:  Florent Ginhoux; Martin Guilliams
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

Review 3.  Epidemiology of valvular heart disease in the adult.

Authors:  Bernard Iung; Alec Vahanian
Journal:  Nat Rev Cardiol       Date:  2011-01-25       Impact factor: 32.419

Review 4.  Embryonic origin of the adult hematopoietic system: advances and questions.

Authors:  Alexander Medvinsky; Stanislav Rybtsov; Samir Taoudi
Journal:  Development       Date:  2011-03       Impact factor: 6.868

5.  Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study.

Authors:  C-C Lu; M-M Liu; G Culshaw; M Clinton; D J Argyle; B M Corcoran
Journal:  Vet J       Date:  2015-03-05       Impact factor: 2.688

Review 6.  Etiology of valvular heart disease-genetic and developmental origins.

Authors:  Joy Lincoln; Vidu Garg
Journal:  Circ J       Date:  2014-07-07       Impact factor: 2.993

Review 7.  Abandoning M1/M2 for a Network Model of Macrophage Function.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

8.  Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.

Authors:  Arnar Geirsson; Mansher Singh; Rahmat Ali; Hussain Abbas; Wei Li; Juan A Sanchez; Sabet Hashim; George Tellides
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

Review 9.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

10.  Notch-Tnf signalling is required for development and homeostasis of arterial valves.

Authors:  Yidong Wang; Bingruo Wu; Emily Farrar; Wendy Lui; Pengfei Lu; Donghong Zhang; Christina M Alfieri; Kai Mao; Ming Chu; Di Yang; Di Xu; Michael Rauchman; Verdon Taylor; Simon J Conway; Katherine E Yutzey; Jonathan T Butcher; Bin Zhou
Journal:  Eur Heart J       Date:  2017-03-01       Impact factor: 35.855

View more
  6 in total

1.  Lineage tracing clarifies the cellular origin of tissue-resident macrophages in the developing heart.

Authors:  Kuo Liu; Hengwei Jin; Muxue Tang; Shaohua Zhang; Xueying Tian; Mingjun Zhang; Ximeng Han; Xiuxiu Liu; Juan Tang; Wenjuan Pu; Yan Li; Lingjuan He; Zhongzhou Yang; Kathy O Lui; Bin Zhou
Journal:  J Cell Biol       Date:  2022-04-28       Impact factor: 8.077

2.  The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.

Authors:  Qiyu Tang; Andrew J McNair; Kanchan Phadwal; Vicky E Macrae; Brendan M Corcoran
Journal:  Front Cardiovasc Med       Date:  2022-05-17

3.  A Comprehensive miRNome Analysis of Macrophages Isolated from db/db Mice and Selected miRNAs Involved in Metabolic Syndrome-Associated Cardiac Remodeling.

Authors:  Justyna Niderla-Bielińska; Aneta Ścieżyńska; Aneta Moskalik; Ewa Jankowska-Steifer; Krzysztof Bartkowiak; Mateusz Bartkowiak; Ewelina Kiernozek; Anna Podgórska; Bogdan Ciszek; Barbara Majchrzak; Anna Ratajska
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

Review 4.  Collagen Fibrillogenesis in the Mitral Valve: It's a Matter of Compliance.

Authors:  Richard L Goodwin; Arash Kheradvar; Russell A Norris; Robert L Price; Jay D Potts
Journal:  J Cardiovasc Dev Dis       Date:  2021-08-20

Review 5.  Immunity and inflammation: the neglected key players in congenital heart disease?

Authors:  Laura M Wienecke; Sarah Cohen; Johann Bauersachs; Alexandre Mebazaa; Benjamin G Chousterman
Journal:  Heart Fail Rev       Date:  2021-12-02       Impact factor: 4.654

Review 6.  Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling.

Authors:  Nikolaos Poulis; Marcy Martin; Simon P Hoerstrup; Maximilian Y Emmert; Emanuela S Fioretta
Journal:  Front Cardiovasc Med       Date:  2022-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.